Back to Results
First PageMeta Content
Organofluorides / Benzamides / Lactams / MDV3100 / Thioureas / Prostate cancer / Bicalutamide / Latrepirdine / Astellas Pharma / Chemistry / Organic chemistry / Nitriles


  Contacts: Medivation Patrick Machado, Chief Financial Officer Tel: [removed]
Add to Reading List

Document Date: 2009-10-28 20:18:54

Open Document

File Size: 67,38 KB

Share Result on Facebook

City

SAN FRANCISCO / TOKYO / /

Company

Aquilo Partners L.P. / Cooley Godward Kronish LLP / Astellas Pharma Inc. / Medivation Inc. / Pfizer Inc / Covington & Burling LLP / M.D. / /

Continent

Europe / South America / /

Country

South Africa / Japan / United States / Canada / Australia / /

Currency

USD / /

Event

Business Partnership / FDA Phase / Conference Call / Funding / /

/

IndustryTerm

treatment of these diseases / TREATMENT OF PROSTATE CANCER / treatment of Alzheimer’s and Huntington diseases / pharmaceutical / biopharmaceutical / pharmaceuticals / manufacturing / /

MedicalCondition

bicalutamide-resistant cancers / common non-skin cancer / castration-resistant prostate cancer / early-stage prostate cancer / Huntington disease / fatigue / Huntington diseases / prostate cancer / tumor / serious diseases / cancer / tumors / disease / Metabolic Diseases / severe Alzheimer’s disease / prostate cancer disease / lung cancer / diseases / Infectious Diseases / /

MedicalTreatment

chemotherapy / /

MusicAlbum

South America / /

Organization

American Cancer Society / Securities and Exchange Commission / /

Person

Masafumi Nogimori / David Hung / Patrick Machado / /

/

Position

Chief Financial Officer / global category leader / legal adviser / president and chief executive officer / Private / /

Product

bicalutamide / testosterone / MDV3100 / /

ProvinceOrState

California / /

Technology

Neuroscience / chemotherapy / /

URL

www.medivation.com / http /

SocialTag